MABFC - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79206752
Serial Number
79206752
Registration Number
5415118
Word Mark
MABFC
Status
700 - Registered
Status Date
2018-03-06
Filing Date
2016-12-14
Registration Number
5415118
Registration Date
2018-03-06
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260501 - Triangles as borders or carriers.
Published for Opposition Date
2017-12-19
Law Office Assigned Location Code
L10
Employee Name
POWERS, ALEXANDER L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the Greek letter delta to the left of the stylized term "MABFC", with the letters "M" and "F" capitalized and the remainder in lower case letters.
Goods and Services
Pharmaceutical products and preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; medicines for cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; protein supplements; diagnostic kits consisting primarily of monoclonal antibodies and fragment crystallizable proteins, buffers, and reagents for use in disease testing
Goods and Services
Scientific and technological services, namely, scientific research and analysis in the field of monoclonal antibodies and fragment crystallizable proteins; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; scientific study and research in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; research and development in the field of the prevention and the treatment of cancer, autoimmune disorders, inflammatory disorders, viral and bacterial infections, blood diseases; cellular and molecular biological research; design and development of medical products, namely, pharmaceutical compositions of monoclonal antibodies and fragment crystallizable proteins; testing, inspection or research of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; consulting in the field of medical research; engineering; genetic engineering; platform technology, namely, protein expression platform for research and development of pharmaceuticals; platform technology, namely, protein expression platform for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; laboratory services in the field of monoclonal antibodies
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-05-08
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-05-08
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Monte L. Falcoff/Jessica S. Sachs
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1342987
International Registration Date
2016-12-14
International Publication Date
2017-05-04
International Renewal Date
2026-12-14
Auto Protection Date
2022-10-01
International Status
001 - Request for extension of protection established
International Status Date
2017-05-04
Priority Claimed In
True
Priority Claimed Date
2016-09-28
First Refusal In
True
Trademark Events
Event DateEvent Description
2017-05-04SN ASSIGNED FOR SECT 66A APPL FROM IB
2017-05-08NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-05-08ASSIGNED TO EXAMINER
2017-05-10NON-FINAL ACTION WRITTEN
2017-05-11NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2017-05-12APPLICATION FILING RECEIPT MAILED
2017-05-18REFUSAL PROCESSED BY MPU
2017-05-18NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2017-06-03REFUSAL PROCESSED BY IB
2017-10-24TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-11-03ASSIGNED TO LIE
2017-11-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-11-14TEAS/EMAIL CORRESPONDENCE ENTERED
2017-11-15APPROVED FOR PUB - PRINCIPAL REGISTER
2017-11-29NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-11-29NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2017-11-29NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2017-12-15NOTIFICATION PROCESSED BY IB
2017-12-19PUBLISHED FOR OPPOSITION
2017-12-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-03-06REGISTERED-PRINCIPAL REGISTER
2018-06-06FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2018-06-08GENERIC MADRID TRANSACTION CREATED
2018-06-08GENERIC MADRID TRANSACTION SENT TO IB
2018-08-17FINAL DECISION TRANSACTION PROCESSED BY IB
2021-03-05NEW REPRESENTATIVE AT IB RECEIVED
2021-04-03CORRECTION TRANSACTION RECEIVED FROM IB
2021-04-09NEW REPRESENTATIVE AT IB RECEIVED
2021-04-26CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED